Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-08-03 4:41 pm Purchase | 13D | TURNSTONE BIOLOGICS CORP COM TSBX | Versant Venture Capital V L.P. | 2,899,216 12.5% | 2,899,216 (New Position) | View |
| 2023-02-09 4:30 pm Unchanged | 13G | GRITSTONE BIO INC GRTS | Versant Venture Capital V L.P. | 2,895,695 3.5% | 0 (Unchanged) | View |
| 2023-01-06 4:19 pm Sale | 13D | REPARE THERAPEUTICS INC RPTX | Versant Venture Capital V L.P. | 2,094,451 5% | -250,000 (-10.66%) | View |
| 2022-06-13 4:38 pm Sale | 13D | REPARE THERAPEUTICS INC RPTX | Versant Venture Capital V L.P. | 2,344,451 5.6% | -250,000 (-9.64%) | View |
| 2022-02-10 8:21 pm Sale | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Versant Venture Capital V L.P. | 382,961 0.8% | -1,512,041 (-79.79%) | View |
| 2022-02-10 7:58 pm Unchanged | 13G | GRITSTONE BIO INC GRTS | Versant Venture Capital V L.P. | 2,895,695 4.3% | 0 (Unchanged) | View |
| 2021-08-16 4:57 pm Unchanged | 13D | REPARE THERAPEUTICS INC RPTX | Versant Venture Capital V L.P. | 2,594,451 7% | 0 (Unchanged) | View |
| 2021-04-19 6:05 pm Purchase | 13D | VECTIVBIO HLDG AG VECT | Versant Venture Capital V L.P. | 2,791,748 8.2% | 2,791,748 (New Position) | View |
| 2021-02-26 4:36 pm Sale | 13D | REPARE THERAPEUTICS INC RPTX | Versant Venture Capital V L.P. | 2,594,451 7.1% | -550,000 (-17.49%) | View |
| 2021-02-16 07:30 am Unchanged | 13G | GRITSTONE BIO INC GRTS | Versant Venture Capital V L.P. | 2,895,695 6.1% | 0 (Unchanged) | View |
| 2021-02-12 8:27 pm Sale | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Versant Venture Capital V L.P. | 1,895,002 5.8% | -789,560 (-29.41%) | View |
| 2021-01-25 4:27 pm Sale | 13D | REPARE THERAPEUTICS INC RPTX | Versant Venture Capital V L.P. | 3,144,451 8.6% | -275,000 (-8.04%) | View |
| 2020-07-06 9:31 pm Purchase | 13D | REPARE THERAPEUTICS INC RPTX | Versant Venture Capital V L.P. | 3,419,451 9.3% | 3,419,451 (New Position) | View |
| 2020-02-14 11:39 am Sale | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Versant Venture Capital V L.P. | 2,684,562 10.9% | -473,689 (-15.00%) | View |